Literature DB >> 10623787

Nicotine microaerosol inhaler.

P G Andrus1, R Rhem, J Rosenfeld, M B Dolovich.   

Abstract

OBJECTIVE: To measure the droplet size distribution of a nicotine pressurized metered-dose inhaler using a nicotine in ethanol solution formulation with hydrofluoroalkane as propellant.
MATERIALS AND METHODS: Sizing was performed at room temperature by multistage liquid impinger and quartz crystal impactor.
RESULTS: The mass median aerodynamic diameter of the nicotine aerosol produced was measured at 1.6 mm by multistage liquid impinger and 1.5 mm by quartz crystal impactor.
CONCLUSIONS: The inhaler formulation used produces a microaerosol of sufficiently fine droplet size that mimics the puff-by-puff pulmonary arterial bolus nicotine delivery of tobacco smoke. The absence of combustion products such as heat, carcinogens and carbon monoxide permits safer nicotine delivery via the inhaler than is possible via smoked tobacco.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10623787     DOI: 10.1155/1999/530496

Source DB:  PubMed          Journal:  Can Respir J        ISSN: 1198-2241            Impact factor:   2.409


  3 in total

Review 1.  Novel delivery systems for nicotine replacement therapy as an aid to smoking cessation and for harm reduction: rationale, and evidence for advantages over existing systems.

Authors:  Lion Shahab; Leonie S Brose; Robert West
Journal:  CNS Drugs       Date:  2013-12       Impact factor: 5.749

2.  The Effect of Electronic Cigarette User Modifications and E-liquid Adulteration on the Particle Size Profile of an Aerosolized Product.

Authors:  Haley A Mulder; Jesse L Patterson; Matthew S Halquist; Leon Kosmider; Joseph B McGee Turner; Justin L Poklis; Alphonse Poklis; Michelle R Peace
Journal:  Sci Rep       Date:  2019-07-15       Impact factor: 4.379

3.  Acute pulmonary effects of aerosolized nicotine.

Authors:  Shama Ahmad; Iram Zafar; Nithya Mariappan; Maroof Husain; Chih-Chang Wei; Nilam Vetal; Isam A Eltoum; Aftab Ahmad
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-10-25       Impact factor: 6.011

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.